Subscribe To
Altice (atus) beats on q3 earnings despite lower revenues
Altice's (ATUS) third-quarter 2023 results reflect the adverse impact of a challenging macroeconomic en...
November 2, 2023, 9:46 am
Fed rate hikes peaking? top-ranked etfs to buy
Stock markets rallied on Nov 1, 2023 in response to two significant factors including the Fed's possibl...
November 2, 2023, 9:46 am
Tyler technologies (tyl) q3 earnings beat, revenues miss
Tyler Technologies' (TYL) third-quarter 2023 performance reflects robust year-over-year growth in subsc...
November 2, 2023, 9:46 am
This elite ultra-high-yielding dividend stock adds $3.1 billion in additional fuel to its growth engine
Enterprise Products Partners secured another $3.1 billion in expansion projects. They'll come online in 202...
November 2, 2023, 9:39 am
Delta is laying off corporate workers. cost pressures are mounting for airlines.
The carrier confirmed plans to lay off some corporate workers as it looks to “better manage costs” in 202<...
November 2, 2023, 9:37 am
Eur/gbp technical: medium-term bullish basing as boe looms
Three key technical developments have suggested that the EUR/GBP cross pair has formed a potential medium-term bullish basing configuration since 23 A...
November 2, 2023, 9:31 am
Novavax to host conference call to discuss third quarter 2023 financial results and operational highlights on november 9, 2023
GAITHERSBURG, Md. , Nov. 2, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advanc...
November 2, 2023, 9:25 am
Talon metals signs agreement with us doe for $114.8m in bipartisan infrastructure law funding
Talon Metals Corp. (TSX:TLO, OTC:TLOFF) told investors it has signed a definitive agreement with the US Department of Energy (DOE) setting the terms, ...
November 2, 2023, 9:24 am
Federal reserve maintains the status quo: overview for november 02, 2023
After the November meeting of the Federal Reserve, the EUR/USD pair maintained its neutral position. The post Federal Reserve Maintains the Status Quo...
November 2, 2023, 9:24 am
The aud surges to three-week highs: overview for november 02, 2023
The AUD/USD pair strengthens its position while the US dollar remains neutral. The post The AUD Surges to Three-Week Highs: Overview for November 02, ...
November 2, 2023, 9:21 am
Technical analysis & forecast november 02, 2023
Brent's Decline Continues. This analysis also encompasses the movements of EUR, GBP, JPY, CHF, AUD, Gold, and the S&P 500 index. The post Technical An...
November 2, 2023, 9:18 am
Lucid diagnostics to present at canaccord genuity medtech, diagnostics, and digital health & services forum
Lishan Aklog, M.D., Chairman & CEO, to Present November 16, 2023, in New York NEW YORK , Nov. 2, ...
November 2, 2023, 9:18 am
In8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceut...
November 2, 2023, 9:17 am
Corvus pharmaceuticals to present new interim soquelitinib data from its phase 1/1b t cell lymphoma trial at the 65th american society of hematology (ash) annual meeting & exposition
BURLINGAME, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a c...
November 2, 2023, 9:15 am
Best small business loans 2023
If the business doesn’t have sufficient cash reserves to fund their plans, a small business loan can bridge the gap. Indeed, the British Business Ba...
November 2, 2023, 9:14 am
Editas medicine to present clinical data from the ruby and edithal trials of edit-301 at the ash 2023 annual meeting and in a company-sponsored webinar
Company to host a webinar to discuss EDIT-301 clinical data on Monday, December 11, at 1:00 p.m. ET Dr. Rabi Hanna from Cleveland Clinic Children's to...
November 2, 2023, 9:12 am
Vincerx pharma to present three posters at ash 2023 in december
VIP943 poster supports selectivity and safety of lead CD123 ADC, VIP943, currently in Phase 1 VIP924 poster shows this novel CXCR5-ADC compares favora...
November 2, 2023, 9:10 am
Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato
BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today ...
November 2, 2023, 9:09 am
Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato
BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today ...
November 2, 2023, 9:09 am
7 value stocks to buy while they are still out of the limelight
Although 2023 has witnessed a massive surge in relevant industries – most notably artificial intellig...
November 2, 2023, 9:02 am